Lexaria Signs Master Collaborative Research AgreementMaster Collaborative Research Agreement • February 14th, 2017 • Lexaria Bioscience Corp. • Metal mining
Kelowna, BC / February 8, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”), through its wholly owned Canadian subsidiary Lexaria Canpharm Corp., has signed and entered a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions.
Canada Canada Research AgreementMaster Collaborative Research Agreement • June 3rd, 2020 • Lexaria Bioscience Corp. • Metal mining • Ontario
WHEREAS the Parties have common interests in the development of specialty and functional ingredients for differentiated consumer markets involving functional food, nutrition, and health and wellness applications;
Lexaria Signs Master Collaborative Research AgreementMaster Collaborative Research Agreement • March 29th, 2022
Lexaria believes that results from this scientific collaboration could motivate license adoption of Lexaria's patented flavour masking and nutrient delivery enhancement technology, including but not limited to the vitamin, pain reliever and nicotine sectors. Lexaria's technology is patented in the US, and patent pending in Canada and in 41 other countries around the world.
Canada Canada Research AgreementMaster Collaborative Research Agreement • January 5th, 2018 • Lexaria Bioscience Corp. • Metal mining • Ontario
WHEREAS the Parties have common interests in the development of specialty and functional ingredients for differentiated consumer markets involving functional food, nutrition, and health and wellness applications;
